Equibles does not estimate personal net worth.
Get an email with a short summary when Silence Therapeutics plc publishes a filing, an earnings call transcript or a press release.
Get SLN alertsCurtis Ramarin has spoken on 1 investor event across 1 company, most recently for Silence Therapeutics plc on May 19, 2026. Silence Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Silence Therapeutics plc includes Craig Tooman (CEO), Iain Ross (CEO and Chairman), Rhonda Hellums (CFO and Board Member) and 3 others.
“We are focused on developing precision type medicines based on our sRNA technology. And we have a platform called the miRNA Gold Platform. So the Gold Platform is designed to deliver medicines that are targeted, long duration of effect, and very potent.”
Transcript header (unverified)
Biotechnology · Healthcare
